A Study of LY4175408 in Participants With Advanced Cancer
Eli Lilly and Company
Eli Lilly and Company
Kivu Bioscience Inc.
Exelixis
Bristol-Myers Squibb
AbbVie
Novartis
Exscientia AI Limited
Genmab
Zumutor Biologics Inc.
IDEAYA Biosciences
Radiopharm Theranostics, Ltd
Eli Lilly and Company
Bristol-Myers Squibb
AstraZeneca
Eisai Inc.
Novartis
PMV Pharmaceuticals, Inc
Mayo Clinic
BeOne Medicines
Aktis Oncology, Inc.
Memorial Sloan Kettering Cancer Center
Sumitomo Pharma America, Inc.
Seagen Inc.
Radiopharm Theranostics, Ltd
Tizona Therapeutics, Inc
A2 Biotherapeutics Inc.
Exscientia AI Limited
NiKang Therapeutics, Inc.
SystImmune Inc.
Eli Lilly and Company
Jacobio Pharmaceuticals Co., Ltd.
Elephas
Innate Pharma
Dren Bio
Compass Therapeutics
Brown University
Janux Therapeutics
Institut Bergonié
Hadassah Medical Organization
Circle Pharma
Nurix Therapeutics, Inc.
A2 Biotherapeutics Inc.
Memgen, Inc.
University of California, Irvine
Medicenna Therapeutics, Inc.
Monopar Therapeutics
Monopar Therapeutics
Cofactor Genomics, Inc.
Simcha IL-18, Inc.
CytosinLab Therapeutics Co., Ltd.